Abortion Pill Makers Seek Supreme Court Ruling Pause

On Saturday, two companies that manufacture mifepristone came to the court, asking the justices to pause a ruling by the U.S. Court of Appeals for the 5th Circuit in a lawsuit by Louisiana that reinstated the requirement that the drug, which is used in about 60% of abortions nationwide, be dispensed only in person. The companies, Danco Laboratories and GenBioPro, both told the justices that the 5th Circuit’s order was “unprecedented.” Danco argued that the order “injects immediate confusion and upheaval into highly time-sensitive medical decisions,” while GenBioPro said that the order “has unleashed regulatory chaos.” Nearly two years ago, the Supreme Court ruled that doctors and medical groups opposed to abortion did not have a legal right to sue, known as standing, to challenge the Food and Drug Administration’s expansion of access to mifepristone. Alliance for Hippocratic Medicine, was filed in federal court in Texas by several individual doctors who are opposed to abortion on religious or moral grounds, as well as medical groups whose members are opposed to abortion.